InterMune, Inc. (ITMN)
$13.56
-0.16 (-1.17%)
| CAPS Rating |
|
|---|---|
| Open | $13.73 |
| Previous Close | $13.72 |
| Daily Range | $13.34 - $13.92 |
| 52-Week Range | $8.66 - $19.12 |
| Market Cap | $625.28M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 438,310 |
| Average Daily Volume | 369,000 |
ITMN
VS S&P 500 (SPY)
How do you think ITMN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ITMN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ITMN News and Commentary
- Earnings? Yawn. Trial Data? Moving! – The Motley Fool
- 9 Things You Should Do Instead of Buying Stocks – The Motley Fool
- Stocks to Avoid Now? – The Motley Fool
- Fearful Stocks for Greedy Investors – The Motley Fool
- Vertex Combines to Keep From Being Ground Up – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- 9 Stocks to Shake the Market – The Motley Fool
- 5 Deathbed Stocks – The Motley Fool
- InterMune Batting .500 – The Motley Fool
- Bought puts on Intermune (ITMN) – Blog at The Motley Fool
- Mark Your Calendars: The Race Is On! – The Motley Fool
- Get Ready for the Fall? – The Motley Fool
- 9 Things You Should Do Instead of Buying Stocks – The Motley Fool
- 2 Ways to Beat the Recession With Stocks – The Motley Fool
- InterMune Previews a Coming Attraction – The Motley Fool
- Telaprevir Tests Its Luck – The Motley Fool
- Vertex on the Verge of Victory – The Motley Fool
- Vertex Doesn't Disappoint – The Motley Fool
- Nice Results for InterMune's Orphan Drug – The Motley Fool
- Hep C Drugs Slug It Out – The Motley Fool
RSS Headlines
Fool UK
